Serina Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)
Serina Therapeutics, Inc. (SER) reported Diluted Shares Outstanding (Weighted Average) of 16.39 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- Serina Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 16.39M shares, a 63.78% increase year-over-year.
- Serina Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 12.05M shares, a 23.48% increase year-over-year.
- Serina Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 10.66M shares, a 17.01% increase year-over-year.
- Serina Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 10.34M shares, a 3.83% decline year-over-year.
- Serina Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 10.19M shares, a 38.47% increase from fiscal 2024.
- Serina Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 7.36M shares, a 0.11% increase from fiscal 2023.
- Serina Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 7.35M shares, a 681178.96% increase from fiscal 2022.
- Serina Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 1.08K shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 16.39M shares 10-Q · filed 2026-08-13 | 14.23M shares 10-Q · filed 2026-08-13 | 13.03M shares derived: average of 3 quarters · filed 2026-08-13 | 12.36M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 12.05M shares 10-Q · filed 2026-05-14 | 11.36M shares derived: average of 2 quarters · filed 2026-05-14 | 11.02M shares derived: average of 3 quarters · filed 2026-05-14 | 10.76M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 10.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 10.50M shares derived: average of 2 quarters · filed 2026-03-25 | 10.34M shares derived: average of 3 quarters · filed 2026-08-13 | 10.19M shares 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | 10.34M shares 10-Q · filed 2025-11-13 | 10.17M shares derived: average of 2 quarters · filed 2026-08-13 | 10.03M shares 10-Q · filed 2025-11-13 | 9.80M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 10.00M shares 10-Q · filed 2026-08-13 | 9.88M shares 10-Q · filed 2026-08-13 | 9.62M shares derived: average of 3 quarters · filed 2026-08-13 | 9.91M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 9.76M shares 10-Q · filed 2026-05-14 | 9.44M shares derived: average of 2 quarters · filed 2026-05-14 | 9.87M shares derived: average of 3 quarters · filed 2026-05-14 | 9.94M shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 9.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 9.93M shares derived: average of 2 quarters · filed 2026-03-25 | 10.01M shares derived: average of 3 quarters · filed 2026-03-25 | 7.36M shares 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | 10.75M shares 10-Q · filed 2025-11-13 | 10.45M shares derived: average of 2 quarters · filed 2025-11-13 | 6.77M shares 10-Q · filed 2025-11-13 | 7.61M shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 10.16M shares 10-Q · filed 2025-08-11 | 10.16K shares 10-Q · filed 2024-08-09 | 5.65M shares 10-Q · filed 2025-08-11 | 5.65K shares 10-Q · filed 2024-08-09 | 6.57M shares derived: average of 3 quarters · filed 2025-08-11 | 6.82M shares derived: average of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | 2.79M shares 10-Q · filed 2025-05-08 | 4.78M shares derived: average of 2 quarters · filed 2025-05-08 | 5.71M shares derived: average of 3 quarters · filed 2025-05-08 | 4.29M shares derived: average of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | 6.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 7.17M shares derived: average of 2 quarters · filed 2025-03-24 | 4.78M shares derived: average of 3 quarters · filed 2025-03-24 | 7.35M shares 10-K · filed 2025-03-24 | 1.08K shares 10-K · filed 2024-03-22 | |||
| 2023-09-30 | 7.58M shares 10-Q · filed 2024-11-12 | 37.95K shares 10-Q · filed 2023-11-14 | 3.80M shares derived: average of 2 quarters · filed 2024-11-12 | 7.55M shares 10-Q · filed 2024-11-12 | 37.95K shares 10-Q · filed 2023-11-14 | 4.01M shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 7.43K shares 10-Q · filed 2024-08-09 | 37.95K shares 10-Q · filed 2023-08-14 | 7.43K shares 10-Q · filed 2024-08-09 | 37.95K shares 10-Q · filed 2023-08-14 | 2.82M shares derived: average of 3 quarters · filed 2024-08-09 | 2.13M shares derived: average of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | 8.57M shares 10-Q · filed 2024-05-14 | 4.23M shares derived: average of 2 quarters · filed 2024-05-14 | 2.83M shares derived: average of 3 quarters · filed 2024-05-14 | 2.13M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -109.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -35.78K shares derived: average of 2 quarters · filed 2024-03-22 | -11.21K shares derived: average of 3 quarters · filed 2024-03-22 | 1.08K shares 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | 37.95K shares 10-Q · filed 2023-11-14 | 37.94K shares derived: average of 2 quarters · filed 2023-11-14 | 37.94K shares 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | 37.94K shares 10-Q · filed 2023-08-14 | 37.94K shares 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | 37.94M shares 10-Q · filed 2022-05-13 | |||||||
| 2021-03-31 | 37.73M shares 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |